Confusing terminology used in the abbreviation of pharmacy journal names

The lack of commonly agreed terminology in pharmacy field is highly prevalent and may have influence on the relevance and robustness of the area, especially how others see pharmacy literature. Potential consequences of this poor perception of pharmacy field by the National Library of Medicine (NLM)...

Full description

Saved in:
Bibliographic Details
Published inResearch in social and administrative pharmacy Vol. 18; no. 8; pp. 3463 - 3465
Main Authors Fernandez‐Llimos, Fernando, Mendes, Antonio M., Tonin, Fernanda S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2022
Online AccessGet full text

Cover

Loading…
More Information
Summary:The lack of commonly agreed terminology in pharmacy field is highly prevalent and may have influence on the relevance and robustness of the area, especially how others see pharmacy literature. Potential consequences of this poor perception of pharmacy field by the National Library of Medicine (NLM) could be the omission of several pharmacy-related Medical Subject Headings (MeSH) or the low indexing rate of pharmacy practice journals in MEDLINE. Journal name abbreviation, under the responsibility of the NLM, is the unambiguous way to identify a journal in bibliographic references and catalogs. The present study investigated the consistency of pharmacy journal abbreviations in the NLM Catalog. For the 290 journals containing any word with the root pharm in their names, a consistent procedure for NLM title abbreviations was found for 27 of the words in journal names but not for the abbreviation “Pharm”, which represented several words with very different meanings: pharmaceutical, pharmaceutics, pharmacists, and pharmacy. The use by the NLM of different abbreviation for pharmaceutical and pharmaceutics would increase journal identification clarity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1551-7411
1934-8150
DOI:10.1016/j.sapharm.2022.01.003